Company Snapshot: CAH  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Cardinal Health Announces Preliminary Shareholder Voting Results at Annual Meeting
 
Board of Directors Declares Regular Quarterly Dividend

DUBLIN, Ohio, Nov. 5 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced the preliminary results of shareholder voting at the company's annual meeting, and the board of directors declared its 97th consecutive regular quarterly dividend.

Based on preliminary voting results, shareholders re-elected 12 directors to the board, ratified the company's external auditor and approved three management proposals relating to corporate governance. These proposals included a majority voting provision for directors, the elimination of cumulative voting and the establishment of procedures for advance notice of director nominations and other business at shareholder meetings. In addition, management proposals relating to stated capital of common shares and amendments to two employee stock plans were approved. A shareholder proposal relating to performance-based stock options failed to pass.

The board of directors also approved a regular quarterly dividend of $0.14 per share, payable on Jan. 15, 2009 to shareholders of record on Jan. 1, 2009. For more than 24 years, Cardinal Health has paid a quarterly dividend to shareholders. The company had approximately 360 million shares outstanding as of Oct. 31.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(TM) electronic infection surveillance service, VIASYS(R) respiratory care products and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at http://www.cardinalhealth.com .


SOURCE Cardinal Health, Inc.